Swiss National Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.9M | Buy |
580,500
+43,000
| +8% | +$2.36M | 0.02% | 538 |
|
|
2025
Q1 | $38M | Sell |
537,500
-300
| -0.1% | -$21.2K | 0.03% | 476 |
|
|
2024
Q4 | $35.3M | Sell |
537,800
-25,800
| -5% | -$1.7M | 0.02% | 503 |
|
|
2024
Q3 | $39.6M | Buy |
563,600
+1,700
| +0.3% | +$119K | 0.03% | 497 |
|
|
2024
Q2 | $46.3M | Sell |
561,900
-2,300
| -0.4% | -$189K | 0.03% | 433 |
|
|
2024
Q1 | $49.3M | Sell |
564,200
-24,200
| -4% | -$2.11M | 0.03% | 426 |
|
|
2023
Q4 | $56.7M | Sell |
588,400
-15,400
| -3% | -$1.48M | 0.04% | 378 |
|
|
2023
Q3 | $53.4M | Sell |
603,800
-73,700
| -11% | -$6.52M | 0.04% | 377 |
|
|
2023
Q2 | $58.7M | Sell |
677,500
-60,100
| -8% | -$5.21M | 0.04% | 399 |
|
|
2023
Q1 | $71.7M | Sell |
737,600
-16,200
| -2% | -$1.58M | 0.05% | 354 |
|
|
2022
Q4 | $78M | Sell |
753,800
-47,998
| -6% | -$4.97M | 0.06% | 330 |
|
|
2022
Q3 | $68M | Buy |
801,798
+3,500
| +0.4% | +$297K | 0.05% | 358 |
|
|
2022
Q2 | $66.2M | Buy |
798,298
+3,100
| +0.4% | +$257K | 0.04% | 377 |
|
|
2022
Q1 | $61.3M | Buy |
795,198
+98,300
| +14% | +$7.58M | 0.03% | 462 |
|
|
2021
Q4 | $61.6M | Sell |
696,898
-25,700
| -4% | -$2.27M | 0.04% | 442 |
|
|
2021
Q3 | $55.9M | Sell |
722,598
-20,200
| -3% | -$1.56M | 0.04% | 460 |
|
|
2021
Q2 | $62M | Buy |
742,798
+45,566
| +7% | +$3.8M | 0.04% | 448 |
|
|
2021
Q1 | $52.6M | Buy |
697,232
+12,100
| +2% | +$914K | 0.04% | 481 |
|
|
2020
Q4 | $60.1M | Sell |
685,132
-18,800
| -3% | -$1.65M | 0.04% | 416 |
|
|
2020
Q3 | $53.6M | Sell |
703,932
-7,300
| -1% | -$555K | 0.04% | 395 |
|
|
2020
Q2 | $87.7M | Buy |
711,232
+14,100
| +2% | +$1.74M | 0.07% | 269 |
|
|
2020
Q1 | $58.9M | Buy |
697,132
+131,200
| +23% | +$11.1M | 0.06% | 303 |
|
|
2019
Q4 | $47.9M | Sell |
565,932
-25,400
| -4% | -$2.15M | 0.05% | 380 |
|
|
2019
Q3 | $39.9M | Buy |
591,332
+9,632
| +2% | +$649K | 0.04% | 424 |
|
|
2019
Q2 | $49.8M | Sell |
581,700
-12,600
| -2% | -$1.08M | 0.05% | 360 |
|
|
2019
Q1 | $52.8M | Buy |
594,300
+17,100
| +3% | +$1.52M | 0.06% | 336 |
|
|
2018
Q4 | $49.1M | Buy |
577,200
+13,000
| +2% | +$1.11M | 0.06% | 309 |
|
|
2018
Q3 | $54.7M | Sell |
564,200
-16,900
| -3% | -$1.64M | 0.06% | 326 |
|
|
2018
Q2 | $54.7M | Buy |
581,100
+17,600
| +3% | +$1.66M | 0.06% | 324 |
|
|
2018
Q1 | $45.7M | Sell |
563,500
-82,600
| -13% | -$6.7M | 0.06% | 360 |
|
|
2017
Q4 | $57.6M | Buy |
646,100
+2,900
| +0.5% | +$259K | 0.06% | 320 |
|
|
2017
Q3 | $59.9M | Buy |
643,200
+11,600
| +2% | +$1.08M | 0.07% | 298 |
|
|
2017
Q2 | $57.4M | Buy |
631,600
+22,200
| +4% | +$2.02M | 0.07% | 303 |
|
|
2017
Q1 | $53.5M | Buy |
609,400
+143,300
| +31% | +$12.6M | 0.07% | 306 |
|
|
2016
Q4 | $38.6M | Buy |
466,100
+17,500
| +4% | +$1.45M | 0.06% | 343 |
|
|
2016
Q3 | $41.5M | Sell |
448,600
-4,400
| -1% | -$407K | 0.07% | 316 |
|
|
2016
Q2 | $35.2M | Buy |
453,000
+34,100
| +8% | +$2.65M | 0.06% | 354 |
|
|
2016
Q1 | $33.1M | Buy |
418,900
+127,300
| +44% | +$10.1M | 0.06% | 330 |
|
|
2015
Q4 | $30.5M | Buy |
291,600
+5,500
| +2% | +$576K | 0.07% | 284 |
|
|
2015
Q3 | $30.1M | Buy |
286,100
+29,300
| +11% | +$3.09M | 0.08% | 274 |
|
|
2015
Q2 | $35.1M | Buy |
256,800
+19,200
| +8% | +$2.63M | 0.09% | 251 |
|
|
2015
Q1 | $29.6M | Buy |
237,600
+101,500
| +75% | +$12.6M | 0.08% | 274 |
|
|
2014
Q4 | $12.3M | Sell |
136,100
-3,100
| -2% | -$280K | 0.05% | 380 |
|
|
2014
Q3 | $10M | Sell |
139,200
-800
| -0.6% | -$57.7K | 0.04% | 425 |
|
|
2014
Q2 | $8.71M | Buy |
140,000
+2,100
| +2% | +$131K | 0.03% | 480 |
|
|
2014
Q1 | $9.41M | Sell |
137,900
-11,400
| -8% | -$778K | 0.04% | 435 |
|
|
2013
Q4 | $10.5M | Sell |
149,300
-1,300
| -0.9% | -$91.3K | 0.04% | 418 |
|
|
2013
Q3 | $10.9M | Buy |
150,600
+16,400
| +12% | +$1.18M | 0.05% | 398 |
|
|
2013
Q2 | $7.49M | Buy |
+134,200
| New | +$7.49M | 0.03% | 480 |
|